Core participant in One Health EJP, a major European joint programme on foodborne diseases, antimicrobial resistance, and cross-species disease surveillance.
VYZKUMNY USTAV VETERINARNIHO LEKARSTVI
Czech veterinary research institute specializing in foodborne zoonoses, natural antimicrobials, and sustainable animal feed across European One Health consortia.
Their core work
The Veterinary Research Institute (VRI) in Brno is a Czech public research institute focused on animal health, food safety, and veterinary science. Their core work spans microbiology, parasitology, and epidemiology of foodborne zoonoses, with growing activity in natural bioactive compounds for animal treatment and sustainable protein sources for animal feed. They contribute laboratory expertise and applied research to large European consortia tackling One Health challenges — where animal health, food safety, and human health intersect.
What they specialise in
NeoGiANT project (their largest by funding) explores grape-derived polyphenols as antibiotic alternatives for animal treatment, including antimastitis applications and feed enhancement.
ALEHOOP project focuses on macroalgae and legume by-product valorisation for farmed fish, pig, and poultry feed formulations.
Microbiology and parasitology are explicit competencies in One Health EJP and underpin their antimicrobial research in NeoGiANT.
AMR is a cross-cutting theme in both One Health EJP (surveillance of resistance) and NeoGiANT (reducing antibiotic use through natural alternatives).
How they've shifted over time
VRI's H2020 trajectory shows a clear shift from surveillance-oriented veterinary epidemiology toward applied bioactive solutions. Their earliest project (One Health EJP, 2018) centred on disease monitoring, foodborne pathogen tracking, and health policy — classical veterinary public health. By 2020-2021, their newer projects (ALEHOOP, NeoGiANT) moved into tangible product development: sustainable feed ingredients and natural antimicrobial compounds from plant extracts. This signals a pivot from observing problems to developing practical interventions.
VRI is moving toward applied, product-oriented research in antibiotic alternatives and sustainable feed, making them increasingly relevant for agri-food companies seeking green veterinary solutions.
How they like to work
VRI operates exclusively as a participant, never coordinating — they bring specialist veterinary and laboratory expertise into consortia led by others. With 81 unique partners across 23 countries from just 3 projects, they work in very large consortia (especially the One Health EJP network). This means they are well-connected and accustomed to multi-partner coordination, but potential collaborators should expect them as a contributing expert rather than a project driver.
Despite only 3 H2020 projects, VRI has built an unusually broad network of 81 partners across 23 countries, largely thanks to the One Health EJP mega-consortium. Their reach spans most of Europe with no narrow geographic bias.
What sets them apart
VRI sits at a distinctive intersection: they combine deep veterinary microbiology and parasitology expertise with emerging capabilities in natural bioactive compounds and sustainable feed science. For consortium builders, this means a single partner that can address both the disease surveillance side and the applied product development side of One Health and food safety projects. Their position as a dedicated veterinary research institute (not a university department) gives them focused infrastructure and institutional continuity in this niche.
Highlights from their portfolio
- NeoGiANTTheir largest H2020 contribution (EUR 518,938), exploring grape polyphenols as antibiotic replacements in animal health — a commercially relevant topic with growing regulatory demand.
- One Health EJPA massive European Joint Programme connecting veterinary, food safety, and public health institutes across dozens of countries — gave VRI access to the continent's One Health network.
- ALEHOOPBridges VRI's veterinary expertise into sustainable protein and circular bioeconomy territory, showing their ability to contribute beyond traditional animal health research.